These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 29159069)
1. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC). Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069 [TBL] [Abstract][Full Text] [Related]
2. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
3. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X Front Physiol; 2018; 9():399. PubMed ID: 29720944 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma. Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H PeerJ; 2019; 7():e8096. PubMed ID: 31788359 [TBL] [Abstract][Full Text] [Related]
5. Identification of Yang H; Wang Y; Zhang Z; Li H Front Genet; 2020; 11():905. PubMed ID: 32973873 [TBL] [Abstract][Full Text] [Related]
6. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma. Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812 [No Abstract] [Full Text] [Related]
7. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942 [TBL] [Abstract][Full Text] [Related]
8. Identifying a Novel Biomarker Xiong Y; Yuan L; Chen L; Zhu Y; Zhang S; Liu X; Xiao Y; Wang X J Cancer; 2018; 9(21):3912-3922. PubMed ID: 30410595 [TBL] [Abstract][Full Text] [Related]
9. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. Qu G; Wang H; Yan H; Liu G; Wu M Front Oncol; 2022; 12():857619. PubMed ID: 35296026 [TBL] [Abstract][Full Text] [Related]
10. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma. Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390 [TBL] [Abstract][Full Text] [Related]
11. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma. Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783 [No Abstract] [Full Text] [Related]
12. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis. Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845 [TBL] [Abstract][Full Text] [Related]
13. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
14. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma. Wei W; Lv Y; Gan Z; Zhang Y; Han X; Xu Z Oncol Lett; 2019 May; 17(5):4321-4328. PubMed ID: 30988807 [TBL] [Abstract][Full Text] [Related]
15. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma. Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141 [TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes associated with outcome of clear cell renal cell carcinoma. Li R; Wang L; Wang X; Geng RX; Li N; Liu XH Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839 [TBL] [Abstract][Full Text] [Related]
17. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280 [TBL] [Abstract][Full Text] [Related]
18. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis. Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X Front Oncol; 2019; 9():957. PubMed ID: 31649873 [TBL] [Abstract][Full Text] [Related]
19. Integration of bioinformatics analysis to identify possible hub genes and important pathways associated with clear cell renal cell carcinoma. Kumar A; Yadav RP; Chatterjee S; Das M; Pal DK Urologia; 2024 May; 91(2):261-269. PubMed ID: 38159064 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma. Luo T; Chen X; Zeng S; Guan B; Hu B; Meng Y; Liu F; Wong T; Lu Y; Yun C; Hocher B; Yin L Oncol Lett; 2018 Aug; 16(2):1747-1757. PubMed ID: 30008862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]